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A case of cutis laxa acquisita was studied with the aim 
ot defining the molecular defects involved and com-
paring them with those of an inherited form of cutis 
laxa. In the acquisita form of cutis laxa ultrastructural 
and biochemical observations confirmed a dramatic 
reduction of dermal elastin, whereas collagen content 
W'as normal. Elastin mRNA expression as well as tro-
poelastin production by dermal fibroblasts, in vitro, 
W'ere normal compared with control cells, as revealed 
by in situ hybridization and enzyme-linked immuno-
sorbent assay, respectively. Lysyl oxidase activity, 
measured on cultured fibroblasts, was reduced to 60% 
compared with age-matched control subjects. Unlike 
control skin fibroblasts or fibroblasts from inherited 
C utis laxa (CL) may be inherited as an autosomal dom-inant or autosomal recessive form. In addition, it may occur in association with an autosomal recessive form of pseudoxanthoma elasticum, or with an autosomal dominant form of amyloidosis, as an acquired form 
after inflammatory skin lesions, or as a drug reaction [1]. 
The molecular bases of this disease remain elusive. Light and 
electron microscopy have shown that dermal elastin content is se-
verely reduced, suggesting that the major abnormality might lie in 
elastin metabolism [1]. Biochemical and molecular analyses of skin 
fibroblasts have confirmed defects in elastin production or gene 
expression in some but not all cases examined [2,3]. However, in 
some patients, alterations of the collagen component, such as fu-
sions of fibrils, have also been described [1]. 
Having identified a man, who, at the age of 18, began to present 
the classic signs of the disorder, we performed ultrastructural, bio-
chemical, and biomolecular evaluation to provide more compre-
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cutis laxa, the affected skin cells from cutis laxa ac-
quisita predominantly expressed an elastolytic activity 
identified as cathepsin G. Patient serum also has re-
duced elastase inhibitory capacity and reduced levels 
of a1-antiproteinase inhibitor (a1-antitrypsin). Al-
though cutis laxa acquisita is a heterogeneous group of 
disorders, findings in this patient were consistent with 
excessive loss of cutaneous elastin due to the combined 
effects of several factors, such as low lysyl oxidase ac-
tivity together with high levels of cathepsin G and re-
duction of circulating proteinase inhibitor(s). Key 
words: cathepsin G/proteases/skin/lung/in vitro. ] Invest 
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hensive information on the acquired form of this rare disease. Data 
were compared with those of age-matched control subjects and 
those of an infant with the classical form of autosomal recessive CL. 
MATERIALS AND METHODS 
Case Histories 
Clltis Laxa Acqtl isita (CLA) Patient: A 27-year-old man, who had appar-
ently been healthy until the age of 18, showed progressive aging of the entire 
skin, aggravated by a period of prolonged exposure to sun, which was also 
responsible for fever and edema. Skin biopsies were perfonned at the age of 
27 and 32 to evaluate the progression of the disease. Skin elasticity, measured 
with a Schiaparelli Diagnostic Ismunit, was 50- 70% of control subjects 
depending on the different sites tested. Echotomography showed a normal 
structure of both the aorta and the iliac arteries. Radiographic analyses of 
the thorax demonstrated a moderate obstructive respiratory insufficiency. 
Nasal mucociliary clearance was estimated by the saccharin test (n = 3) [4) 
and transport time was always greater than 60 min (nonnal values are 
< 30 min). 
CL Patiellt: A 4-month-old boy with a classical form of cutis laxa was 
hospitalized because of markedly loose and redundant skin, delayed devel-
opment, neurologic disturbances, and cranial and facial dismornsm. There 
was no consanguinity between parents, nor history of similarly affected 
family members. Mucopolysaccharides and oligosaccharides in the urine 
were nonna!. 
Biochemical Analysis Frozen lyophilized skin samples from the fore-
arm region of the two patients and of age-matched control subjects were 
weighed, hydrolyzed in 1 mI 6 N Hel (110·C, 24 h), and divided into 
aliquots for amino acid analysis and crosslink determination. One hundred 
microliters of hydrolysate was dried, derivatized with phenylisothiocarba-
mate, and hydroxyproline and proline values were taken from high-perfor-
mance liquid chromatography (HPLC) chromatograms, as previously de-
scribed (5) . Using the remaining hydrolysate, crosslinks were fractioned 
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from other amino acid residues by the Skinner method [5] and resolved on a 
150 X 4.6 mm ODS-5 column (Altex) in an isocratic system developed by 
James e/ at [6] . for the resolution of collagen (pyridinoline) crosslinks from 
which. under standard conditions. desmosine and isodesmosine were well 
resolved. 
Electron Microscopy Forearm and abdominal punch biopsies from pa-
tients and from site- and age-matched control subjects. and respiratory epi-
thelium of the CLA patient. were fixed in 2.5% glutaraldehyde (Poly-
sciences. Warrington, PAl in Tyrode's solution and were routinely 
processed for electron microscopy. 
Cell Cultures Fibroblasts, from forearm punch biopsies from the two 
patients and from age-matched control cases, were isolated and cultured in 
Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% 
fetal bovine serum, antibiotics. and L-glutamine (Sigma, St. Louis, MO); the 
medium was changed every 2 d unless otherwise specified. For all experi-
ments cells from control subjects and patients were cultured in parallel and 
were used from the third through the sixth passages. Measurements of cell 
growth were obtained by cell counting from day 1 to day 6 and by [3H]-thy-
midine (Amersham, UK) incorporation into DNA. 
In Situ Hybridization Cells, grown on eight-chamber slides (Nunc Inc., 
Naperville, IL) in DMEM plus 10% fetal bovine serum (Sigma) until con-
fluence, were fixed with 4% paraformaldehyde (Fluka, Buchs. CH) in phos-
phate-buffered saline (PBS), pretreated with acetic anhydride (0.25% in 
0.1 M triethanolamine [Flub] pH 8, 10 min at 25 QC), formamide ([Fisher, 
Fairlawn, NJ]60% in 0.2% saline sodium citrate [SSe], 10 min at 65°C). 
Control slides were digested with RNAse-A ([Sigma] 75 Jig/ml, 1 h at 
37°C). Specimens were hybridized as already described [7]. The following 
cDNA probes, labeled by random primer extension (Pharmacia, Piscataway, 
NJ) with deoxycytidine 5'(alpha-thiol) triphosphate W5S]-dCTP) (Dupont, 
Wilmington, DE) [8] were used: collagen type I (Hf1131) [9] and elastin 
(cHE-4) [10]. To quantitate the signal. the number of silver grains per cell 
was measured. 
Enzyme-Linked Immunosorbent Assay (ELISA) 
Tropoelastin Prodl4ctiotl: Cells, grown in eight-chamber slides until con-
fluence, were re-fed with DMEM plus 10% newborn bovine serum and, 
after 48 h, medium was collected and lyophilized until assay, and the cell 
monolayer was suspended in 10 mM ethylenediaminetetraacetic acid 
(EDTA), pH 12.3, and frozen for DNA estimation by a fluorimetric DNA 
assay [11] . The ELISA was performed as previously described [12] . 
Elas/ill Peptides: Elastin peptide levels in serum and urine were quantified 
by enzyme-linked immunoassay as previously described [12,13]. 
Lysyl Oxidase Assay Cells, grown in DMEM plus 10% fetal bovine 
serum (Sigma) until confluence, were placed in DMEM plus 5 mg/ml bo-
vine serum albumin (Sigma) and 50 Jig/ml ascorbate (BDH, Poole, UK) for 
24 h. For lysyl oxidase assay, the tritium release method described by Pel-
tonen e/ at [14] was used. Briefly, fibroblast culture media were incubated for 
20 h at 37°C with a chick embryo aortic elastin substrate radiolabeled with 
L-[4,5-3H]-lysine hydrochloride (Amersham) [15] and the difference in the 
amount of tritiated water produced in the presence and absence of p-amino-
propionitrile (Sigma) was quantified. 
Protease Assay 
Elastolytic Ac/ivity: Aliquots of fibroblast extract (or concentrated culture 
media) were incubated with a tritiated elastin prepared by radiolabeling 
bovine nuchal ligament elastin (Sigma) with PH] sodium borohydride (New 
England Nuclear, Boston, MA) to a specific activity of 5.8 X 105 dpm/mg 
of elastin, according to a procedure previously described in detail [16]. The 
radioactivity released in the supernatant of the reaction was used as a measure 
of the enzyme activity. 
Protease Activities 011 Synthetic Substrates: Elastase-like, cathepsin G, and 
cathepsin L activities were determined on concentrated cell extracts (or 
media) on the synthetic substrates N-succinyl-L-alanyl-L-alanyl-L-alanyl-
p-nitroaniline (SAAApNA) (Sigma) [17], N-succinyl-L-alanyl-L-alanyl-
L-prolyl-phenylalanyl-p-nitroaniline (SAAPPpNA) (Sigma) [18], and ben-
zyloxycarbonyl-L-phenyl-L-arginyl-7-amido-4-methylcoumarin (Z-Phe-
Arg-NMec) (Sigma) [19]. 
Inllibi/or Assay: Inhibition of fibroblast activities hydrolyzing tritium-la-
beled elastin was performed by pre-incubating extracts of cultured cells with 
buffer (0 .1 M Hepes, pH 7.5, 0.5 M NaCI, 5 mM CaCl2 , 0.1% Brij35) or 
buffer containing the following inhibitors: 1 mM phenylmethylsulfonyl 
fluoride (PMSF) dissolved in isopropanol. 1 mM EDTA, 1 mM o-phen-
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
60 o collagen 







'" ~ 20 
~ 
0 
Control CL CLA 
Figure 1. Dermal collagen and elastin content. Frozen skin samples 
from control cases and from the CL and CLA patients were analyzed by 
HPLC; values are expressed as percent of dry weight of tissue, assuming 
hydroxyproline is 11 .3% of the mass of collagen and desmosine plus isodes-
mosine are 1.4% of the mass of elastin. Elastin was markedly reduced in 
patients. compared with control subjects. 
anthroline. or 100 ,ug/ml elastatinal (Sigma). Inhibition of enzyme activity 
was expressed as percentage of inhibition calculated from remaining activity 
and control subjects. Enzyme activiry was linear during the assay. 
[mml41lOtitratiotl oj Cathepsitl G: Immunoadsorption of cathepsin G with 
rabbit anti-human cathepsin G antibodies (Calbiochem, San Diego, CAl was 
performed essentially as described by Verheijen et al [20]. Briefly, increased 
amounts of an anti-cathepsin G immunoglobulin (Ig)G or control IgG from 
nonimmune serum, purified using a protein A-Sepharose column, were 
added to cell extracts of cultured fibroblasts and incubated at 25 ° C for 
60 min. Antibody-antigen complexes were removed by addition of forma-
lin-fixed Stapllytococcus aureus (Cowas strain) (Sigma) followed by centrifu-
gation. The remaining enzyme activity towards SAAPPpNa and ['H]-elastin 
was measured in the supernatants. 
Serum Elastase brhibitory Capacity (EIC) : Serum was tested for £IC against 
porcine pancreatic elastase (PPE) on SAAApN A as elastase substrate, accord-
ing to Klumpp and Bieth [21]. Serum diluted 41 times with water was used 
in all experiments. 
Serllm a1-Antitrypsi" (AAT) COllcentratiotls: Concentrations of serum 
AA T were determined by single radial immunodiffusion [22] on Nor-Parti-
gen plates (Behering, Germany). 
RESULTS 
Biochemical analysis, performed by HPLC on skin biopsies (Fig 1), 
demonstrated an 80% decrease of dermal elastin in the CLA patient, 
compared with control subjects, whereas the amount of collagen 
was normal. The decrease of elastin in the patient suffering from 
CLA was comparable to that of the patient a.ffected by severe peri-
natal CL, processed in parallel. 
To evaluate the organization of the elastic component, we per-
formed ultrastructural studies on dermal biopsies . Control dermis 
consisted of collagen bundles, characterized by fibrils with rather 
heterogeneous diameters, and by regularly developed elastin fibers 
(Fig 2a). In the CLA patient, as in almost all other CL patients 
studied so far, a dramatic reduction of elastic fibers without signifi-
cant alterations of the collagen component was observed (Fig. 2b,c). 
In particular, elastic fibers were scarce in number, thin, and frag-
mented. Negligible changes were observed in a second biopsy taken 
5 years later (Fig 2c). 
Skin fibroblasts, grown in culture up to the sixth passage, did not 
differ significantly from control cells from the morphologic and 
proliferative points of view, as evaluated by optical microscopy, cell 
counting, and ['H]-thymidine incorporation (data not shown). 
Control and CLA skin fibroblasts, grown in multichambered cul-
ture slides, did not demonstrate significant differences in the levels 
of both elastin and collagen type I mRNAs, as shown by in situ 
hybridization. Other CL strains from the genetic, recessive form of 
the disease, processed following the same protocol, in contrast, gave 
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Figure 2. Ultrastructure of control and CLA dermis. Elastin (E) was 
almost absent in the patient (b,c) compared with normal individuals (a). 
Elastin fibers were small, thin, and consistently fragmented in diseased skin. 
The same features were found in biopsies taken when patient was 27 (b) and 
32 (c) years old. Bars, 111m. 
very weak hybridization signals (data not shown). Cells hybridized 
with the same probes after predigestion with RNAse were negative. 
The amount of tropoelastin secreted in vitro and measured by 
ELISA was similar to control values in the patient affected by CLA; 
by contrast, soluble elastin accumulation was reduced by 50% in the 
patient with an inherited form of CL (Fig 3). Lysyl oxidase activity, 
assayed in the culture medium, was reduced 40% in the patient with 
CLA, compared with age-matched control subjects (Fig 4). The 
enzyme activity was 60% decreased in the other CL strain used for 
comparison. 
The hydrolytic enzyme actIVIties towards [3H]-elastin, 
SAAApNA, SAAPPpNA, and Z-Phe-Arg-NMec substrates from 
both normal and diseased fibroblasts are reported in Table I. Ex-
tracts prepared from control and pathologic fibroblasts exhibited 
similar hydrolytic enzyme activities towards [3H]-elastin and 
SAAApNA substrate (elastase-like), whereas only fibroblast extracts 
from the CLA patient exhibited a prominent hydrolytic activity 
towards the SAAPPpNA (cathepsin G) and Z-Phe-Arg-N Mec sub-
strates (cathepsin L) (Table I). The effects of inhibitors on the 
elastolytic activities from the various fibroblast preparations are 
shown in Table IT. As can be seen, the elastolytic activity from the 
patient suffering CL and from control subjects was almost com-
pletely inhibited by EDTA or o-phenanthroline (inhibitors of me-
talloproteinases) and by elastatinal (an actinomyces peptide inhibi-
tor reported as specific for elastases) [23]' whereas it was completely 
insensitive to PMSF (a strong inhibitor of serine proteases) . This 
finding suggests the presence in these cell extracts of an elastase 
belonging to the metalloproteinase class. Conversely, the enzyme 
activity expressed by fibroblasts of the patient with CLA was highly 
inhibited by PMSF, partially inhibited by o-phenanthroline or 
EDTA in the presence of Ca++ ions, and insensitive to elastatinal 
(Table IT). These data strongly suggest the presence, in fibroblasts 
of the CLA patient, of an elastolytic enzyme with a substrate speci-
ficity and inhibition profile overlapping that of cathepsin G. This 
view was further confirmed by immunotitration experiments per-
formed with monospecific antibodies raised against purified human 
cathepsin G. As shown in Fig 5, virtually all enzyme activities 
towards SAAAPpNA and [3H]-elastin were found to decrease pro-
gressively at increasing antibody concentrations (see also Materials 
and Methods). This feature was not observed when nonimmune con-













Figure 3. Tropoelastin secreted in vitro by control and diseased fi-
broblasts (CL and CLA) measured by ELISA. Values represent the 
mean ± SD of triplicate determinations for the various fibroblast strains: 
control subjects (number 2). and the CL and CLA patients. The amount of 
tropoelastin produced by dermal fibroblasts appeared reduced only in the 
patient with CL. 







Figure 4. Lysyl oxidase activity measured on culture medium of 
control and diseased fibroblasts (CL and CLA). The culture medium 
was incubated with a fiKed amount of radiolabeled elastin and the amount of 
tritiated water was taken as an eKpression of the enzyme activity, which was 
markedly reduced in both CL and CLA patients. Values represent the 
mean ± SD of at least triplicate determinations for the various fibroblast 
strains: controls, CL and CLA patients. 
extracts from the CL patient and other normal subjects treated with 
IgG either from nonimmune or immune serum (data not shown). 
Serum from the CLA-affected patient exhibited consistently 
lower EIC values compared with healthy subjects, as mean values 
were 1.87 ± 0.2 and 3.63 ± 0.5 mg of porcine pancreatic elastase 
inhibited by 1 ml of serum, respectively (Fig 6) . Moreover, serum 
a1-antitrypsin concentration determined by single radial immuno-
diffusion was 1.35 ± 0.11 in the CLA patient and 2.69 ± 0.69 in 
the control group (Fig 7). The amounts of elastin peptides, mea-
sured in both serum and urine, were similar in the patient suffering 
from CLA and in normal subjects (Table ITI). 
Radiographic examinations and poor response to the saccharin 
test, designed to evaluate the flow of mucous secretions [4], sug-
gested possible respiratory complications. However, ultrastructural 
examination of respiratory epithelium revealed only moderate al-
terations in ciliary morphology and excluded the presence of a pri-
mary ciliary dyskinesia. 
DISCUSSION 
In the acquired form of cutis laxa dermal elastin is greatly affected, 
although in the most severe cases other farts , such as blood vessels, 
lungs, and heart, can be involved as well 1] . In the patient described 
in this study, the more striking abnormalities were found in dermal 
elastin, and from the patient's history it appeared that the beginning 
of elastin alterations may be related to abrupt, prolonged, and in-
ten~e sun exposures followed by edema and sometimes fever. 
Biochemical analyses using HPLC confirmed the diagnosis of 
CLA, revealing a marked reduction of dermal elastin, assayed by the 
desmosine and isodesmosine content [5]. On the contrary, the 
amount of collagen appeared normal. Therefore, by comparison, 
the ratio between elastin and collagen was as markedly reduced in 
the patient affected by CLA as in the patient suffering an inherited 
form of CL. 
Morphologic studies showed a marked scarcity of dermal elastin 
fibers that were fragmented and spongiform in CLA, compared 
Table I. Hydrolysis of SAAApNA, SAAPPpNA, Z-Phe-
Arg-NMec, and pHI-Elastin by Dermal Fibroblasts· 
SAAApNA SAAPPpNA Z-Phe-Arg-NMec [3H]-Elastin 
Control 2.16 ± 1.47 0.07 ± 0.02 1.09 ± 0.31 6.3 ± 2.5 
cases 
CL 1.29 ± 0.09 0.06 ± 0.01 1.26 ± 0.02 4.0 ± 0.6 
CLA 1.70 ± 0.10 1.83 ± 0.036 3.43 ± 0.136 5.2 ± 0.7 
• Enzyme activity reported as 11M nitroanilide/min/IO· cells (SAAApNA and 
SAAPl'pNA), 11M X 10· 7-amino-4-methylcoumarin/min/lO· cells (Z-l'hc-Arg-
NMcc) and dl'm X 10'/h/l0· cells (['H]-elastin). Values represent the l11ean (±SD) of 
at least triplicate determinations for the various fibroblast strains: control subjects 
(number 7). CL. and CLA patients. 
• 2p S 0.0004. 
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Table IT. Effect ofInhibitors on the Hydrolysis of (3H]-
Elastin by Human Derm.al Fibroblasts· 
Control Cases CL CLA 
EDTA 0% 1% 44% 
O -phenanthroline 0% 0% 74% 
PMSF 100% 100% 4% 
Elastatinal 6% 8% 100% 
• Values, obtained from three different measurements, represent, within each sa_mple. 
the residual activity expressed as percentage of control hydrolyzing activity without 
inhibitors, wh ich were 7.5 ± 2.1.4.0 ± 0.6. and 5.2 ± 0.7 (dpm X 10'/h/l0' cells) 
for control subjects (no. 2), and for CL and CLA patients. respectively. Cell extracts 
were preincubated with each inhibitor as described in Materials alld Methods. 
with control subjects. Dermal blood vessels appeared normal and no 
significant alterations were observed in the organization of collagen 
fibrils and fibers, suggesting once more that in CL, and also in the 
acquisita phenotype, the main defect resides in dermal elastin. 
To determine whether the reduced amount of elastin was due to 
decreased synthetic capacity, as observed in other forms of CL [2,3]' 
we estimated collagen type I and elastin mRNA expression by in situ 
hybridization on skin-cultured fibroblasts. The results seemed to 
exclude this possibility, as evaluation of elastin and type I collagen 
mRNA expression did not reveal significant differences in cells 
from the CLA patient and control subjects. Other CL strains that 
show reduced elastin mRNA by conventional filter hybridization 
gave a very low hybridization signal in this assay (Giro MG: unpub-
lished observations). Moreover, the amount of tropoelastin pro-
duced by the CLA fibroblasts was normal, whereas it was signifi-
cantly reduced in cells from the patient with CL (2p s; 0.01). 
In the present study, the Iysyl oxidase (LO) activity in the me-
dium of cultured fibroblasts was found to be significantly reduced in 
both cutis laxa strains compared with control cells (2p s; 0.001). 
Whether the deficjent enzyme activity is the cause and/or conse-
quence of the rare and thin elastin fibers, observed by electron mi-
croscopy in this and other connective tissue disorders [14,24,25], is 
unknown. The greatest reduction of LO activity was observed in 
the CL fibroblasts, probably contributing to the severity of the 
clinical manifestations observed in this patient. In the subject with 
CLA, it could be possible that the reduced level ofLO activity led to 
an impaired assembly and stability of tropoelastin molecules in the 
elastin fibers and perhaps to an increased susceptibility of elastin to 
proteases [26 - 29]. 
Extracts from both control and CL dermal fibroblasts expressed 
moderate amounts of e1astolytic activity, which could be largely 
ascribed to the presence of a metalloproteinase sensitive to EDTA, 
o-phenanthroline, and e1astatinal, and insensitive to PMSF [30,31]. 
Actually, both the 72- and 92-kDa gelatinases have been found as 
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Figure 5. lmmunotitration of cathepsin G activity. Increasing 
amollnts of anti-cathepsin G IgG were incubated with cell eKtracts of the 
CLA patient. The enzyme activity towards SAAPPpNA (ope" squares) and 
[3HJ-elastin (solid sq/lares) decrea:ed proportionally to the amount of IgG 
added to the system. 
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Figure 6. Serum elastase inhibitory capacity. Expressed in milligrams 
of enzyme (porcine pancreatic elastase) per ffillhter. of serum, capacIty was 
strongly reduced in the CLA patient compared wIth normal IndIVIduals. 
Values represent the mean ± SO of at least triplicate determinations for the 
various fibrobl ast strains: age-matched control subjects (number 10), and the 
CLA p atient. 
dini et al have described several metal-dependent elastolytic activi-
ties [33) . On the co~trary, fibroblasts fr~m the .<=:LA patient ex-
pressed consistently high levels of catheps1l1 G actiVity, as measured 
on the specific synthetic substrate S~PPpN:A [18J an.d .confirmed 
by the enzyme sensitivity to the ser~ne protel1~ase .m~lblto~ ~MSF 
and to specific antibodies. Catheps1l1 G: wluch .I~ lllsensltlve ~o 
o-phenanthroline and elastatinal, and partially sensitive to EDT A 111 
the presence of Ca++ ions [34), appeared t? be ~h~ n?ajor enzyme 
against elastin in CLA cell extracts. Cathepsll1 activity ill fibroblasts, 
as well as metallo elastase, were reported by Szendroi et al [35) and 
by Schwarz et al [36) . The elastolyt.ic potent.i~l .of cathepsin. G 
towards elastin fibers [37], as well as Its ll1SenSltivlty to the major 
dermal elastase inhibitor elafin [38), strengthens the view that cath-
epsin G, at least under certain ~ircumstances, might playa role in the 
skin disorders of patlent(s} with CLA. 
The absence of high amounts of elastin peptides, in both serum 
and urine from the CLA patient, suggests that elastin catabolism was 
normal at the time of sampling. This was sustained by the observa-
tion that no differences in the morphology of the elastic component 
were seen in the two biopsies taken 5 years apart. Other cases of 
CLA showing active reduction in cutaneous elastin are character-
ized by high levels of urinary peptides (Davidson JM: in prepara-
tion). . 
The presence of significantly lower Erc and AA T m the serum of 
the CLA patient compared with control subje~ts supports t~e hy-
pothesis that, especially in the presence of environmental stl111ula-
tory factors such as sun exposure, elastin degra~ation co~ld be 
strongly enhanced in this individual. Moreover, 1Jl these c~rcum­
stances, cathepsin G might reinforce the role of other elastm pro-
teases. . d 
Increased elastin degradation has been reported to. b.e associate 
with a deficiency of serum AA T [39] . However, the chmcal data ~nd 
the amount of elastin peptides, measured in both serum and Urine, 
exclude, in the patient suffering from CLA, the presence of emphy-
sema or an ongoing parenchymal lung destruction [40) and strongly 
suggest the idea that elastic tissue in the lung was not affected as 
Contro l CLA 
Figure 7. Serum a1-antitrypsin (AAT) concentrations, determined 
by single radial immunodiffusion, were heavily reduced in the CLA 
patient compared with control case.s. Values represent the mean ± SO 
of triplicate determInations for the vanous fibrob last strall1s: age-matched 
control subjects (number 10), and the CLA patIent. 
Control cases 
CLA 
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Table m. Elastin Peptides' 
Serum 
(ng elastin peptides/ 
ml serum ± SO) 
12.67 ± 8.2 
14.75 ± 4.22 
Urine 
(ng elastin peptides/ 
mg creatinine ± SO) 
112.3 ± 67.8 
85.5 ± 4.6 
II Values were obtained from three dific rcnt mcasUrCtllcnts in control subjects (num-
ber 6) and in the CLA patient. Elastin peptides were measured in serum and urine 
samples were measured by ELISA. 
much as in the skin. On the other hand radiographic analysis, the 
saccharin test, and clinical symptoms (chronic rhinitis, mucus hy-
persecretion, cough, and chronic bronchitis) were consistent with a 
diagnosis of chronic obstructive pulmonary disease. Because signifi-
cant ultrastructural ciliary defects were not observed, we suppose 
that the delayed mucociliary clearance in our patient is related to the 
mucous hypersecretion [4,41] . 
In conclusion, we confirmed that, in the acquired form of cutis 
laxa under investigation, elastin was greatly affected; however, the 
molecular and/or biochemical defect did not reside in altered elastin 
synthesis. Other factors, such as lysyl oxidase, proteases, and their 
inhibitors, seemed to contribute to abnormal elastin catabolic pro-
cesses. In particular, the role of cathepsin G, which was markedly 
expressed in vitro by dermal fibroblasts of the patien.t affect~d by 
CLA, could play an important role 111 the pathogenesIs of t1llS diS-
ease. As regards the respiratory complications, it has been demon-
strated recently that cathepsin G is one of the most potent secreta-
gogues known and is abl~ to induce mucous disch~ge and 
hypersecretion in the bronchial tree at 10- 10 M concentratIon [42). 
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